Chargement en cours...

The DKA that wasn't: a case of euglycemic diabetic ketoacidosis due to empagliflozin

Sodium glucose co-transporter (SGLT-2) inhibitor is a relatively new medication used to treat diabetes. At present, the Food and Drug Administration (FDA) has only approved three medications (canagliflozin, dapagliflozin and empagliflozin) in this drug class for the management of Type 2 diabetes. In...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oxf Med Case Reports
Auteurs principaux: Candelario, Nellowe, Wykretowicz, Jedrzej
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2016
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4962888/
https://ncbi.nlm.nih.gov/pubmed/27471597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/omcr/omw061
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!